BMS Foundation launches national programme to bolster mental health diversion initiatives: Lawrenceville, New Jersey Saturday, January 17, 2026, 12:00 Hrs [IST] The Bristol Myers ...

Mature biopharma deals are stealing all the headlines, but Bristol Myers Squibb’s Robert Plenge says the company’s deals with ...

Immunai, an AI biotech company specializing in mapping the human immune system, has announced a strategic collaboration with ...

Bristol Myers Squibb is already aiming to launch more than 10 new medicines by 2030. | SAN FRANCISCO—Bristol Myers Squibb is ...

BioNTech (NASDAQ:BNTX) used a presentation and question-and-answer session at the J.P. Morgan Healthcare Conference to ...

Camzyos, which works by blocking the actin-myosin interactions responsible for HCM and, in effect, relaxing the heart, bears ...

Tuesday: Cold; breezy in the afternoon, with a high of 26 and low of 14 degrees.

AbbVie reached a deal with the Trump administration on drug prices in exchange for being exempted from tariffs and future ...

Adimab's latest partner program to receive approval is GSK's Exdensur (depemokimab), approved in the US for the treatment of severe asthma with an eosinophilic phenotype and in the UK and Japan for ...

Distributors and OEM brands are scrutinizing their supply chain to ensure quality and viability over the long term as the global energy shift accelerates. In recent years, the 48V lithium battery ...

During a live event, Omid Hamid, MD, discussed the logistics and multidisciplinary process of using tumor-infiltrating ...

In other HHS news, Dr. Gary Gibbons is retiring as the director of the National Heart, Blood and Lung Institute on January 31 ...